CCEL Q4 2020 Earnings — Cryo-Cell International, Inc. Revenue & Financial Results | Market Cap Arena

CCELCryo-Cell International, Inc.

$26M

Q4 2020 Earnings

Healthcare Medical - Care Facilities

Income Statement

Revenue

$8M-5.4% YoY

Gross Profit

$5M69.3% margin

Operating Income

$2M28.9% margin

Net Income

$1M15.9% margin

EPS (Diluted)

$0.16

QoQ Revenue Growth

-7.1%

Cash Flow

Operating Cash Flow

$3M

Free Cash Flow

$3M

Stock-Based Comp.

$171,374

Balance Sheet

Total Assets

$46M

Total Liabilities

$49M

Stockholders' Equity

-$3M

Cash & Equivalents

$10M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$8M	-5.4%
Gross Profit	$5M	$6M	-7.0%
Operating Income	$2M	$2M	+26.8%
Net Income	$1M	$844,965	+42.0%

Revenue Segments

Processing And Storage Fees

$7M96%

Public Banking

$242,0073%

Product

$43,6801%